New Trichothecenes Isolated from the Marine Algicolous Fungus Trichoderma  brevicompactum

Mar Drugs. 2022 Jan 18;20(2):80. doi: 10.3390/md20020080.

Abstract

Eight trichothecenes, including four new compounds 1-4 and four known entities 5-8, together with one known cyclonerane (9) were isolated from the solid-state fermentation of Trichoderma brevicompactum NTU439 isolated from the marine alga Mastophora rosea. The structures of 1-9 were determined by 1D/2D NMR (nuclear magnetic resonance), MS (mass spectrometry), and IR (infrared spectroscopy) spectroscopic data. All of the compounds were evaluated for cytotoxic activity against HCT-116, PC-3, and SK-Hep-1 cancer cells by the SRB assay, and compound 8 showed promising cytotoxic activity against all three cancer cell lines with the IC50 values of 3.3 ± 0.3, 5.3 ± 0.3, and 1.8 ± 0.8 μM, respectively. Compounds 1-2, 4-6, and 7-8 potently inhibited LPS-induced NO production, and compounds 5 and 8 showed markedly inhibited gelatinolysis of MMP-9 in S1 protein-stimulated THP-1 monocytes.

Keywords: Trichoderma brevicompactum; cytotoxic activities; endophytic fungus; marine alga; trichothecenes.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology*
  • Carcinoma, Hepatocellular / drug therapy
  • Cell Line, Tumor
  • Colorectal Neoplasms / drug therapy
  • HCT116 Cells
  • Humans
  • Hypocreales / metabolism*
  • Inhibitory Concentration 50
  • Liver Neoplasms / drug therapy
  • Magnetic Resonance Spectroscopy
  • Male
  • Mass Spectrometry
  • PC-3 Cells
  • Prostatic Neoplasms / drug therapy
  • Rhodophyta / microbiology
  • Trichothecenes / chemistry
  • Trichothecenes / isolation & purification
  • Trichothecenes / pharmacology*

Substances

  • Antineoplastic Agents
  • Trichothecenes

Supplementary concepts

  • Trichoderma brevicompactum